Nanomedical Diagnostics Partners with Rogue Valley Microdevices to Create Breakthrough

Nanomedical Diagnostics "NanoMed", a Serra Capital II portfolio company, has announced its parternship with Rogue Valley Microdevices to create a breakthrough product. By working together, these two companies have found a way to make a product that will study molecules during pharmaceutical experiments. 

NanoMed is the first company to combine expertise in biology, nanotechnology, surface chemistry, engineering, and manufacturing to create practical and scaleable graphene biological field effect transistor (BioFET) products.